The Minority Career Development Award (CDA) in Lung Cancer from the Lung Cancer Research Foundation (LCRF) supports lung cancer researchers who are from underrepresented communities in biomedical research. Investigators must be from racial or ethnic groups that are underrepresented in health-related sciences and biomedical research.This includes Blacks or African Americans, Hispanics or Latinos, American Indians or Alaskan Natives, Native Hawaiians and other Pacific Islanders. Individuals from racial or ethnic groups that can demonstrate convincingly that they are underrepresented by the host institution will also be eligible. The research areas supported by the program include:
- Lung cancer biology
- Risk reduction and screening for early detection
- Identification of new biomarkers
- Development of more effective and less toxic therapies including but not limited to targeted and immune-therapies
- Genetic and gene-environment interactions
- Interactions and contributions of multiple factors (e.g. smoking, genetics, environment, societal factors) to disparities in lung cancer outcomes
- Mechanisms of sensitivity and resistance to lung cancer therapies
- Bioengineering approaches to understanding and/or treating lung cancer (i.e., theranostics, biomaterials, nanotechnology, controlled-drug release, and gene therapy)
- Supportive measures for people with lung cancer and their families
- Identification of metabolic vulnerabilities in lung cancer
Applications are open to post-doctoral researchers, clinical fellows, or early- and mid-career investigators with less than 10 years’ experience since their initial faculty appointment. Applicants may be based at universities and research institutions anywhere in the world. The grant provides 75,000 USD/year over 2 years and does not cover indirect costs.
Applications are due on May 31, 2023.
May 31, 2023